These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 6046806)

  • 21. Topical heparin: new observations.
    Cesarone MR; Belcaro G; Errichi S; Cornelli U; Pellegrini L; Ruffini I; Errichi BM; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Cacchio M; Di Renzo A; Hosoi M; Grossi MG; Stuard S; Corsi M
    Angiology; 2007; 58 Suppl 1():16S-20S. PubMed ID: 17478878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
    Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
    Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between heparin and adriamycin in mice bearing the Lewis lung carcinoma.
    Colombo T; Delaini F; Ferrari R; Donati MB; Donelli MG; Poggi A
    Biomedicine; 1981 Dec; 34(3):124-8. PubMed ID: 7337798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a real alternative anticoagulant to heparin in continuous treatments?
    Mariano F; Tetta C; Ronco C; Triolo G
    Expert Rev Med Devices; 2006 Jan; 3(1):5-8. PubMed ID: 16359246
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of the joint administration of heparin and chitosan sulfate ether on hemostatic function].
    Drozd NN; Makarov VA; Bashkov GV; Gal'braĭkh LS; Vikhoreva GA; Gorbacheva IN
    Eksp Klin Farmakol; 1996; 59(1):30-3. PubMed ID: 8704629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change of viscoelastic property and morphology of fibrin affected by antithrombin III and heparin: QCM-Z and AFM study.
    Jung H; Tae G; Kim YH; Johannsmann D
    Colloids Surf B Biointerfaces; 2009 Jan; 68(1):111-9. PubMed ID: 19004623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin is an unsuitable anticoagulant for the detection of plasma ammonia.
    Wannasilp N; Sribhen K; Pussara N; Hwanpuch T; Wangchaijaroenkit S; Opartkiattikul N
    Clin Chim Acta; 2006 Sep; 371(1-2):196-7. PubMed ID: 16678809
    [No Abstract]   [Full Text] [Related]  

  • 28. [Physiological significance and pharmacological action of heparin].
    Gastpar H
    Thromb Diath Haemorrh Suppl; 1965; 16():1-130. PubMed ID: 5334212
    [No Abstract]   [Full Text] [Related]  

  • 29. The influence of epsilon-aminocaproic acid derivatives on the anticoagulant activity of heparin.
    Midura-Nowaczek K; Bruzgo I; Worowski K; Roszkowska-Jakimiec W
    Rocz Akad Med Bialymst; 1998; 43():228-31. PubMed ID: 9972059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro comparative study of the anticoagulant action of lung and gut heparin: part 1.
    Fukuda T; Tatsumi Y; Kimura Y; Maeda H; Okuda K
    Osaka City Med J; 1980; 26(1):19-37. PubMed ID: 7267090
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of a new potent heparin. 1 communication: Determinations of anticoagulant activity of a high potency heparin preparation in vivo using dog as an experimental animal and in vitro using dog and human plasma.
    Bhargava AS; Heinick J; Schöbel C; Günzel P
    Arzneimittelforschung; 1980; 30(6):993-6. PubMed ID: 7191280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The action of heparin as an anticoagulant.
    Shanberge JN
    Wis Med J; 1967 Jul; 66(7):278-80. PubMed ID: 6046806
    [No Abstract]   [Full Text] [Related]  

  • 34. [Heparin--new perspectives on its antiinflammatory action].
    Krasnowska M; Kwaśniewski A
    Postepy Hig Med Dosw; 1995; 49(5):661-9. PubMed ID: 8677228
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.